Schedule 13D ownership disclosure
Emerald Bioscience, Inc.
Security class unavailable · CUSIP: 29102Y101
Event date: 2022-01-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 23.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001640334-22-000205
- Form type
- SC 13D
- Filer
- Emerald Health Sciences Inc.
- CIK
- CIK 1728413
- Filed
- Jan 31, 2022
- Reporting period
- Jan 27, 2022
- Description
- Schedule 13D beneficial ownership